Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (12): 1338-1344.doi: 10.19982/j.issn.1000-6621.20220304
• Original Articles • Previous Articles Next Articles
Shi Jiayun, Wang Manzhi, Zhou Haiyi, Zhang Xiaofo, Wei Songqing()
Received:
2022-08-09
Online:
2022-12-10
Published:
2022-12-02
Contact:
Wei Songqing
E-mail:573508606@qq.com
Supported by:
CLC Number:
Shi Jiayun, Wang Manzhi, Zhou Haiyi, Zhang Xiaofo, Wei Songqing. Dynamic changes and significance of biomarkers of cerebral injury in pediatric tuberculous meningitis[J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1338-1344. doi: 10.19982/j.issn.1000-6621.20220304
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220304
神经组织 标志物 | 结核性脑膜炎组(72例) | 肺结核组 (20例) | Z值a | P值 | ||
---|---|---|---|---|---|---|
完全康复组 (47例) | 预后不良组 (25例) | 合计 | ||||
血清标本 | ||||||
NSE | 13.16(3.22,24.86) | 14.94(8.40,26.90) | 15.12(3.22,26.9) | 7.03(2.48,13.23) | -5.064 | 0.000 |
S100B | 1.03(0.4,2.13) | 1.26(0.40,3.20) | 1.11(0.40,3.20) | 0.25(0.12,0.36) | -6.817 | 0.000 |
GFAP | 13.28(3.44,28.35) | 19.21(6.81,45.82) | 15.34(3.44,45.82) | 10.38(2.41,19.00) | -2.693 | 0.007 |
脑脊液标本 | ||||||
NSE | 29.37(6.50,68.82) | 60.16(24.90,142.70) | 37.90(6.50,142.70) | 7.56(2.12,12.79) | -6.465 | 0.000 |
S100B | 1.97(1.02,6.10) | 2.59(1.32,10.20) | 2.31(1.02,10.20) | 0.35(0.05,0.51) | -6.816 | 0.000 |
GFAP | 45.39(10.87,84.93) | 118.74(58.83,252.60) | 65.31(10.87,252.60) | 7.86(2.41,13.80) | -6.778 | 0.000 |
神经组织标志物 | 完全康复组(47例) | 预后不良组(25例) | Z值 | P值 |
---|---|---|---|---|
NSE | ||||
治疗后1周 | 7.80(3.42,24.83) | 8.53(2.90,34.83) | 3.496 | 0.084 |
治疗后2周 | 7.48(2.29,16.40) | 8.14(2.47,22.67) | 2.614 | 0.116 |
治疗后3周 | 6.64(2.48,13.23) | 7.57(2.30,21.18) | -0.041 | 0.967 |
χ2值 | 2.904 | 1.034 | ||
P值 | 0.085 | 0.079 | ||
S100B | ||||
治疗后1周 | 0.43(0.22,0.95) | 0.51(0.31,1.01) | -0.331 | 0.740 |
治疗后2周 | 0.33(0.11,1.47) | 0.32(0.29,1.13) | -1.745 | 0.081 |
治疗后3周 | 0.34(0.09,0.86) | 0.38(0.05,1.47) | -2.070 | 0.836 |
χ2值 | 1.310 | 0.195 | ||
P值 | 0.193 | 0.202 | ||
GFAP | ||||
治疗后1周 | 14.40(3.44,38.51) | 17.20(9.50,30.63) | -0.940 | 0.347 |
治疗后2周 | 12.86(4.62,28.80) | 13.64(6.83,23.63) | -0.337 | 0.736 |
治疗后3周 | 11.92(4.38,28.80) | 11.49(3.44,26.69) | -0.705 | 0.141 |
χ2值 | 0.632 | 1.690 | ||
P值 | 0.068 | 0.053 |
神经组织标志物 | 完全康复组(47例) | 预后不良组(25例) | Z值 | P值 |
---|---|---|---|---|
NSE | ||||
治疗后1周 | 18.49(4.87,36.12) | 49.58(15.38,87.56) | -2.496 | 0.013 |
治疗后2周 | 14.51(4.87,35.70) | 41.53(9.60,82.00) | -3.815 | 0.000 |
治疗后3周 | 8.53(2.12,21.70) | 25.97(5.56,58.49) | -4.041 | 0.000 |
χ2值 | 43.773 | 16.621 | ||
P值 | 0.000 | 0.000 | ||
S100B | ||||
治疗后1周 | 5.34(2.19,10.08) | 10.15(3.63,15.72) | -3.331 | 0.047 |
治疗后2周 | 0.66(0.19,1.56) | 1.60(0.41,3.28) | -4.745 | 0.000 |
治疗后3周 | 0.40(0.11,0.74) | 0.75(0.41,1.60) | -1.207 | 0.036 |
χ2值 | 87.350 | 33.003 | ||
P值 | 0.000 | 0.000 | ||
GFAP | ||||
治疗后1周 | 45.39(10.87,84.93) | 99.75(65.79,180.84) | -4.940 | 0.000 |
治疗后2周 | 17.77(5.66,38.15) | 63.94(13.65,120.59) | -2.337 | 0.016 |
治疗后3周 | 12.82(5.04,26.90) | 38.03(10.87,85.40) | -3.745 | 0.012 |
χ2值 | 23.684 | 24.299 | ||
P值 | 0.000 | 0.000 |
[1] |
Schaaf HS, Seddon JA. Management of tuberculous meningitis in children. Paediatr Int Child Health, 2021, 41(4): 231-236. doi:10.1080/20469047.2021.1952818.
doi: 10.1080/20469047.2021.1952818 URL |
[2] |
du Preez K, Jenkins HE, Donald PR, et al. Tuberculous Meningitis in Children: A Forgotten Public Health Emergency. Front Neurol, 2022, 17(13): 751133. doi:10.3389/fneur.2022.751133.
doi: 10.3389/fneur.2022.751133 |
[3] |
Daniel BD, Grace GA, Natrajan M. Tuberculous meningitis in children: Clinical management & outcome. Indian J Med Res, 2019, 150(2): 117-130. doi:10.4103/ijmr.IJMR_786_17.
doi: 10.4103/ijmr.IJMR_786_17 URL |
[4] |
Czupryna P, Grygorczuk S, Pancewicz S, et al. Evaluation of NSE and S100B in patients with tick-borne encephalitis. Brain Behav, 2018, 8(12): e01160. doi:10.1002/brb3.1160.
doi: 10.1002/brb3.1160 |
[5] |
Zwirner J, Lier J, Franke H, et al. GFAP positivity in neurons following traumatic brain injuries. Int J Legal Med, 2021, 135(6): 2323-2333. doi:10.1007/s00414-021-02568-1.
doi: 10.1007/s00414-021-02568-1 pmid: 34114049 |
[6] |
Park DW, Park SH, Hwang SK. Serial measurement of S100B and NSE in pediatric traumatic brain injury. Childs Nerv Syst, 2019, 35(2): 343-348. doi:10.1007/s00381-018-3955-y.
doi: 10.1007/s00381-018-3955-y URL |
[7] |
Mai NT, Thwaites GE. Recent advances in the diagnosis and management of tuberculous meningitis. Curr Opin Infect Dis, 2017, 30(1): 123-128. doi:10.1097/QCO.0000000000000331.
doi: 10.1097/QCO.0000000000000331 pmid: 27798497 |
[8] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[9] |
López-Varela E, García-Basteiro AL. World Health Organization guidelines for childhood tuberculosis management: successes achieved and challenges ahead. Pediatr Infect Dis J, 2014, 33(12): 1310-1311. doi:10.1097/INF.0000000000000446.
doi: 10.1097/INF.0000000000000446 pmid: 25386971 |
[10] |
杨汝铃, 龙晓茹, 张祯祯, 等. 222例儿童结核性脑膜炎的临床特征及其预后影响因素分析. 中国防痨杂志, 2020, 42(10): 1053-1060. doi:10.3969/j.issn.1000-6621.2020.10.009.
doi: 10.3969/j.issn.1000-6621.2020.10.009 |
[11] |
Thee S, Basu Roy R, Blázquez-Gamero D, et al. Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study. Clin Infect Dis, 2021, 75(3): 372-381. doi:10.1093/cid/ciab982.
doi: 10.1093/cid/ciab982 URL |
[12] | World Health Organizaion. Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2nd ed. Geneva: World Health Organizaion, 2014. |
[13] |
Rohlwink UK, Mauff K, Wilkinson KA, et al. Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis. Clin Infect Dis, 2017, 65(8): 1298-1307. doi:10.1093/cid/cix540.
doi: 10.1093/cid/cix540 pmid: 28605426 |
[14] |
王莉, 张国军. 血清神经元特异性烯醇化酶与外伤性脑损伤患者及临床特征的关系. 首都医科大学学报, 2021, 42(5):719-720. doi:10.3969/j.issn.1006-7795.2021.05.004.
doi: 10.3969/j.issn.1006-7795.2021.05.004 |
[15] |
Arnason S, Molewijk K, Henningsson AJ, et al. Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis-detection and evaluation as prognostic biomarkers for clinical outcome. Eur J Clin Microbiol Infect Dis, 2022, 41(7): 1051-1057. doi:10.1007/s10096-022-04460-1.
doi: 10.1007/s10096-022-04460-1 URL |
[16] |
Equiza J, Rodríguez-Antigüedad J, Campo-Caballero D, et al. Autoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises. J Neuroimmunol, 2021, 359: 577695. doi:10.1016/j.jneuroim.2021.577695.
doi: 10.1016/j.jneuroim.2021.577695 |
[17] |
DeKosky ST, Kochanek PM, Valadka AB, et al. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients. J Neurotrauma, 2021, 38(1): 1-43. doi:10.1089/neu.2020.7332.
doi: 10.1089/neu.2020.7332 URL |
[18] |
Zurek J, Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp 70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien), 2012, 154(1): 93-103, discussion 103. doi:10.1007/s00701-011-1175-2.
doi: 10.1007/s00701-011-1175-2 URL |
[19] |
Khandare P, Saluja A, Solanki RS, et al. Serum S100B and NSE Levels Correlate With Infarct Size and Bladder-Bowel Involvement Among Acute Ischemic Stroke Patients. J Neurosci Rural Pract, 2022, 13(2): 218-225. doi:10.1055/s-0042-1743214.
doi: 10.1055/s-0042-1743214 pmid: 35694066 |
[20] |
Rohlwink UK, Donald K, Gavine B, et al. Clinical characteri-stics and neurodevelopmental outcomes of children with tuberculous meningitis and hydrocephalus. Dev Med Child Neurol, 2016, 58(5):461-468. doi:10.1111/dmcn.13054.
doi: 10.1111/dmcn.13054 pmid: 26888419 |
[1] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[2] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[3] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[4] | Huang Misun, Wu Yaning, Li Guilian, Liu Haican. Research advances of Mycobacterium tuberculosis enrichment technology [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373. |
[5] | Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163. |
[6] | Liu Ruihua, Sarina , Wang Furong. Interaction between lung cancer and tuberculosis in disease development and progression [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111. |
[7] | Liang Linlong, Pei Yi, Zhou Haiyi, Xie Qifang, Zhang Feng, Jiang Jie, Liu Fuqiang. The epidemiological characteristics and trends of tuberculosis among children aged 0-14 years in Hunan Province from 2014 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 29-35. |
[8] | Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei. Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60. |
[9] | Lu Hailin, Wang Wenfei, Tao Wenhui, Lin Peicong, Chen Xinchun, Deng Guofang, Xie Shuixiang. Oleic acid upregulates the expression of perilipin 2 enhancing macrophage clearance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 72-76. |
[10] | Wang Yilin, Wu Xiao, Pang Yu, Li Shanshan. Immunomodulatory effect of orelabrutinib in host macrophages infected with mycobacterium [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1063-1068. |
[11] | Palidanguli Abudureheman, Wang Senlu, Gulina Badeerhan, Wang Le, Zulikatiayi Abudula, Wang Xinqi, Maiwulajiang Yimamu, Wang Xijiang. Distribution of Mycobacterium tuberculosis genotypes in Kashgar region and their association with clinical characteristics of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1077-1082. |
[12] | Li Qinjing, Jiao Weiwei, Wang Zeming, Shen Adong. Interpretation of clinical standards for drug-susceptible tuberculosis in children and adolescents [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 877-885. |
[13] | Xu Chunhua, Zhu Shiyu, Hu Yi, Yi Kehua, Song Canlei, Wang Zichun, Wu Yong, Wang Qing, Yang Qianru, Shen Xin. Analysis of screening effect of recombinant Mycobacterium tuberculosis fusion protein in screening Mycobacterium tuberculosis infection in close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 897-902. |
[14] | Zhang Lanyue, Wang Yingchao, Liu Weiyi, Shang Xuetian, Jia Hongyan, Zhu Chuanzhi, Zhang Zongde, Pan Liping. Study on the effect of thiol acetyltransferase mshD on the growth and stress response of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 935-941. |
[15] | Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei. Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||